Approval · Notice of Compliance 16636 · 2015
CELECOXIB: Notice of Compliance 16636
Issued February 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16636
- Date
- February 24, 2015
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Non-steroidal anti-inflammatory drug (nsaid)
- Canadian reference product
- CELEBREX (Pfizer Canada Ulc)